Details of the Drug

General Information of Drug (ID: DMHEQQL)

• Drug Name: Dalotuzumab
• Synonyms: AC1MHYZY; SCHEMBL4534994; BDBM82422; NSC_3035240; CAS_109872-41-5; D06396; L000945; 4-amino-N-(1-azabicyclo[3.3.1]nonan-4-yl)-5-chloro-2-methoxybenzamide

Indication

Disease Entry	ICD 11	Status	REF
Breast cancer	2C60-2C65	Phase 2	[1]

• Drug Type: Monoclonal antibody
• Cross-matching ID:
  UNII: 6YI1L648RH
  DrugBank ID: DB11840
  TTD ID: D04BOT

References

• [1] ClinicalTrials.gov (NCT01605396) A Phase II Trial of Ridaforolimus and Exemestane, Compared to Ridaforolimus, Dalotuzumab and Exemestane in Participants With Breast Cancer (MK-8669-064). U.S. National Institutes of Health.